18+ · Research use only
AOD-9604 Philippines
AOD-9604 is a peptide sold by Primara Labs for research use only. It sells as a 10 pack at ₱1,524 a vial; a single vial is ₱2,490 on request. Metro Manila orders before 12 noon arrive the same day; provinces take 1 to 2 days Luzon, 2 to 3 Visayas, 3 to 5 Mindanao. Lab testing: no report published yet, scheduled, see primaralabs.com/coa.
Peptide studied in Phase 2 human trials. Lyophilized powder, stocked in Metro Manila and sold in 10 packs. For laboratory research use only.
Sold as a 10 pack
Pack price replaces the 10% off. One compound per pack.
Pack price replaces the standing 10% off; they don't stack. One compound per pack.
Single vial ₱2,490, on request
Request a single vialCheck out once for the whole cart. Pay by QR, confirm on WhatsApp.
Add more compounds if you like, then check out once. You pay by QR on your order page and send the screenshot on WhatsApp.
In the Philippines
GCash · Maya · QR Ph bank transfer · InstaPay
From abroad
- International transfer
Wise · International bank transfer · Zelle · Crypto
Payment details are sent in the WhatsApp chat once your order is confirmed.
Order by 12 noon on a weekday for same-day Metro Manila
Includes water, syringes, pads · plain box
60-day money-back guaranteeTerms
Order by 12 noon on a weekday for same-day delivery in Metro Manila
Free courier nationwide · Luzon 1-2 days · Visayas 2-3 days · Mindanao 3-5 days
Everything to reconstitute is included
10 x 3ml water · 100 syringes · 100 pads · plain outer packaging
60-day money-back guarantee
If an accredited independent laboratory reports that this vial is not the compound on the label, we refund what you paid for it. Evidence within 60 calendar days of delivery; you do not send anything back. Terms
Delivery proof
Real orders, really delivered

Metro Manila · Same-day
Shipped 1:57 PM, received 2:33 PM. Same day, 36 minutes.

Metro Manila · Customer reply
"Surprised din po ako. Magoorder ako ulit kapag naubos na." They came back and reordered.

Quezon City · Repeat customer
Delivered 11:34 PM. Three weeks later: "Can I order again." "Primara I can say was the best choice."
Real WhatsApp and courier screenshots. Names, numbers and addresses are blacked out.
Updated 16 November 2026
- Human evidence
- Phase 2
- Manufacturing
- cGMP · ISO 9001 · ISO 13485
- Latest batch report
- Scheduled, see /coa
- Storage
- 2 to 8 °C sealed
AOD-9604 in the Philippines
AOD-9604 is a modified fragment from the C-terminal end of human growth hormone, the region linked to the hormone's effect on fat metabolism. It was designed to keep that activity without the hormone's effect on growth, and in obese mice it reduced body weight and body fat.
In people the result was negative. Its developer, Metabolic Pharmaceuticals, stopped obesity development after a phase 2b trial did not show weight loss beyond placebo, and the detailed results were not published in a peer-reviewed journal. A developer-authored summary of its trials reported tolerability similar to placebo.
AOD-9604 comes as a 10 pack of 5mg freeze-dried vials. Refrigerate the vials on arrival and keep reconstituted ones cold. The cart and the WhatsApp button both take the pack; if a single vial is what the work needs, ask in the chat before ordering. Provincial parcels reach 1 to 2 days Luzon, 2 to 3 Visayas, 3 to 5 Mindanao. Background on related metabolic compounds sits in the philippinespeptides.com guides.
Regulatory status
AOD-9604. FDA Philippines: not established. US FDA: Not approved. Checked 16 November 2026.
Sold for laboratory research only, not for human consumption. Primara Labs does not give medical advice or dosing guidance. Regulatory Status Tracker
Laboratory handling
Reconstitution reference
| BAC water added | Resulting concentration | Note |
|---|---|---|
| 1.0 ml | 5 mg/ml | Highest concentration, smallest volumes |
| 2.0 ml | 2.5 mg/ml | Common reference dilution |
Reconstitute with bacteriostatic water. Reference values are for laboratory preparation only. Other volumes: reconstitution calculator, prefilled for AOD-9604 5mg.
Handling and storage
Sealed vials
Store sealed lyophilised vials refrigerated at 2 to 8 °C, away from light.
Primara Labs storage instructionAdding diluent
Add the diluent slowly down the inside wall of the vial rather than straight onto the powder.
Mixing
The US prescribing instructions for tesamorelin, a lyophilised peptide medicine, tell users to swirl the vial to mix the powder and liquid, and not to shake it.
Tesamorelin US instructions for use, DailyMed · checked 23 September 2026Appearance
The same instructions say not to use the solution if it is cloudy, discoloured or has particles in it.
Tesamorelin US instructions for use, DailyMed · checked 23 September 2026After the stopper is punctured
CDC guidance, citing USP chapter 797, is that a multi-dose vial once opened is dated and discarded within 28 days unless the manufacturer states another date, and never used past its original expiry.
CDC, Preventing Unsafe Injection Practices · checked 23 September 2026Benefits studied
Body-weight reduction (not shown)
Phase 2 humanMetabolic Pharmaceuticals ended development of AOD-9604 for obesity in February 2007 after a 24-week phase 2b trial in adults with obesity did not show weight loss beyond placebo; the detailed results were not published in a peer-reviewed journal.
BioWorld, 26 February 2007 · checked 16 November 2026Fat reduction in obese mice
Animal and cellIn obese mice, AOD-9604 reduced body weight and body fat over 14 days, an effect that was absent in mice lacking the beta-3 adrenergic receptor.
Heffernan M et al. Endocrinology 2001, PubMed 11713213 · checked 16 November 2026
Side effects reported
A 2013 summary of six placebo-controlled human trials, written by authors linked to the developer, reported a safety and tolerability profile indistinguishable from placebo and no effect on serum IGF-1.
Stier H et al. J Endocrinol Metab 2013 · checked 16 November 2026When the US FDA placed AOD-9604 in its compounding category 2 in September 2023, it said it had identified serious adverse events that may be associated with AOD-9604, though causality is not clear.
US FDA, bulk drug substances that may present significant safety risks · checked 16 November 2026Findings are described as the research reported them, with the level of evidence for each. They are not a claim about any vial sold here, which is supplied for laboratory research use only.
How it works
AOD-9604 is a modified fragment from the C-terminal end of human growth hormone, designed to keep the hormone's fat-metabolism activity without its effect on growth. In mice its fat-reducing effect was absent in animals lacking the beta-3 adrenergic receptor, though the receptor did not appear to be its direct target.
Targets: No defined receptor; studied for fat metabolism
What the research shows
AOD-9604 is a modified fragment of human growth hormone that reduced body fat in obese mice. Its developer ran human obesity trials, but stopped development in 2007 after a phase 2b trial did not show weight loss beyond placebo. A developer-authored 2013 summary of six trials reported tolerability similar to placebo and no rise in IGF-1.
Animal and cell Mouse studies, and human obesity trials whose phase 2b result was reported by the developer but not published in a peer-reviewed journal.
- In obese mice, AOD-9604 reduced body weight and body fat over 14 days. Endocrinology 2001 · checked 23 September 2026
Lab report: scheduled, see primaralabs.com/coa. No batch report for AOD-9604 is published yet.
- Type
- Modified C-terminal fragment of human growth hormone
- Presentation
- Lyophilized powder, 5 mg / vial
- Vial size
- 5mg
- Catalogue code
- PRM-024
PubChem could not be reached when this SKU was added on 16 November 2026, so no formula, weight or CAS is published from it yet. Published sources differ on the residue numbering of the fragment (177-191 or 176-191), so none is stated.
Frequently asked
AOD-9604 questions, answered
How much is AOD-9604 in the Philippines?
At Primara Labs, AOD-9604 5mg sells as a 10 pack at ₱1,524 per vial (₱15,240 total). A single vial is ₱2,490, available on request on WhatsApp. Prices are in pesos and the pack price is shown on the product page before you order.
Where can I buy AOD-9604 in the Philippines?
Primara Labs sells AOD-9604 5mg as a 10 pack, with single vials on request on WhatsApp. Two ways to order: add to cart and pay by QR (GCash, Maya, QR Ph, InstaPay), or message us on WhatsApp to pay by Wise, international bank transfer, Zelle or crypto.
Do you deliver AOD-9604 to Cebu, Davao and the provinces?
Yes. Metro Manila: same day before 12 noon, Grab Express / Lalamove, ₱150; Luzon: 1 to 2 business days, J&T Express, ₱250; Visayas: 2 to 3 business days, J&T Express, ₱250; Mindanao: 3 to 5 business days, J&T Express, ₱300. Cebu is in the Visayas and Davao in Mindanao. Courier is free on orders over ₱10,000 anywhere in the Philippines. Below that, a Metro Manila rider is ₱150, J&T Express is ₱250 to Luzon and the Visayas and ₱300 to Mindanao.
Is AOD-9604 FDA approved in the Philippines?
AOD-9604. FDA Philippines: not established. US FDA: Not approved. Checked 16 November 2026. Primara Labs supplies it for research use only; it is not for human consumption.
Why is this sold as a 10-pack?
AOD-9604 is sold in 10-packs, at ₱1,524 per vial. Single vials are available on request via WhatsApp at ₱2,490. Delivery times are the same as for the rest of the catalogue.
Is AOD-9604 the same as growth hormone?
No. AOD-9604 is a short modified fragment of human growth hormone, not the whole hormone. It was designed to keep the fragment's fat-metabolism activity without growth effects, and the developer's summary reported no rise in IGF-1.
What is AOD-9604 studied for?
AOD-9604 is a modified fragment of human growth hormone that reduced body fat in obese mice. Its developer ran human obesity trials, but stopped development in 2007 after a phase 2b trial did not show weight loss beyond placebo. A developer-authored 2013 summary of six trials reported tolerability similar to placebo and no rise in IGF-1.
What side effects were reported for AOD-9604?
A 2013 summary of six placebo-controlled human trials, written by authors linked to the developer, reported a safety and tolerability profile indistinguishable from placebo and no effect on serum IGF-1. When the US FDA placed AOD-9604 in its compounding category 2 in September 2023, it said it had identified serious adverse events that may be associated with AOD-9604, though causality is not clear.
How should AOD-9604 be stored?
Store sealed lyophilised vials refrigerated at 2 to 8 °C, away from light. CDC guidance, citing USP chapter 797, is that a multi-dose vial once opened is dated and discarded within 28 days unless the manufacturer states another date, and never used past its original expiry.
Does Primara Labs publish lab reports for AOD-9604?
Lab report: scheduled, see primaralabs.com/coa. No batch report for AOD-9604 is published yet.
All compounds supplied by Primara Labs are for laboratory research use only and are not for human consumption, diagnostic or therapeutic use. Statements on this page describe published research and have not been evaluated by the Philippine FDA. See Research Use Only terms.
